---
title: 'Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS.'
description: >-
  Explore this publication on real-world evidence: Healthcare Disparities in
  Hidradenitis Suppurativa in the US: TARGET-DERM HS..
date: '2026-01-01'
category: Publications
tags:
  - AAD Annual Meeting
  - Poster Presentation
  - R&D
  - Care
  - Dermatology
  - Hidradenitis Suppurativa (HS)
  - Health System Partner
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/aad-annual-meeting/healthcare-disparities-in-hidradenitis-suppurativa-in-the/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: healthcare-disparities-in-hidradenitis-suppurativa-in-the
id: 21cSXQwQvKcGbSzG1x3KNK
contentType: article
---

## Challenge

HS disproportionately affects socioeconomically disadvantaged populations and racial/ethnic minorities, but real-world data characterizing health disparities in HS disease severity, insurance coverage, and biologic utilization across racial groups in a large US/Canadian registry were limited.

## Solution

The TARGET-DERM HS registry was analyzed to compare Hurley staging, comorbidity burden, insurance type, and biologic treatment rates across Non-Hispanic Black, Non-Hispanic White, Hispanic, and other/not-reported patient groups in a cohort of 697 enrolled US HS patients.

## Impact

Documenting that Non-Hispanic Black patients have higher HS disease severity and the lowest private insurance rates—yet the highest biologic utilization—provides a nuanced real-world disparity profile that supports health equity advocacy, diverse enrollment planning, and the design of access programs for HS advanced therapies.

### [Keith D. Knapp](/people/keith-knapp/)

### [Julie M. Crawford](/people/julie-crawford/)